The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Increase in time to initiating cancer therapy and association with worsened survival in curative settings: A U.S. analysis of common solid tumors.
 
Alok A. Khorana
Honoraria - Bayer; Boehringer Ingelheim; Genentech; Halozyme; Janssen; LEO Pharma; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Genentech; Halozyme; Janssen; LEO Pharma; Pfizer; Sanofi
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Halozyme; Janssen; Pfizer
 
Katherine Tullio
No Relationships to Disclose
 
Paul Elson
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck; Newlink Genetics (Inst); Pfizer (Inst)
 
Matthew F. Kalady
Consulting or Advisory Role - Helomics
 
Daniel Raymond
No Relationships to Disclose
 
Eric A. Klein
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - GenomeDx; Genomic Health
 
Jame Abraham
No Relationships to Disclose
 
Stephen R. Grobmyer
No Relationships to Disclose
 
Emily Elizabeth Monteleone
No Relationships to Disclose
 
Brian James Bolwell
No Relationships to Disclose